Key statistics
On Thursday, NovaBay Pharmaceuticals Inc (B9P0:FRA) closed at 2.80, 35.59% above the 52 week low of 2.07 set on Apr 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 2.80 |
Low | 2.80 |
Bid | -- |
Offer | -- |
Previous close | 2.80 |
Average volume | -- |
---|---|
Shares outstanding | 4.89m |
Free float | 4.89m |
P/E (TTM) | -- |
Market cap | 3.52m USD |
EPS (TTM) | -53.22 USD |
Data delayed at least 15 minutes, as of May 30 2024 14:29 BST.
More ▼
Press releases
- NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024
- Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
- NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
- NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
- NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
- NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
More ▼